Prevalence and influencing factors of co-morbid depression in patients with type 2 diabetes mellitus: a General Hospital based study by Weijun Zhang et al.
METABOLIC SYNDROME
DIABETOLOGY & 
Zhang et al. Diabetology & Metabolic Syndrome  (2015) 7:60 
DOI 10.1186/s13098-015-0053-0RESEARCH Open AccessPrevalence and influencing factors of
co-morbid depression in patients with type 2
diabetes mellitus: a General Hospital based study
Weijun Zhang1†, Huiwen Xu2†, Shuliang Zhao3, Shinan Yin4, Xiaohua Wang1, Jing Guo5, Shengfa Zhang1,
Huixuan Zhou1, Fugang Wang1, Linni Gu1, Lei Zhu1, Haibo Yu6, Zhiyong Qu1* and Donghua Tian1*Abstract
Background: Depression and diabetes have been recognized as major public health issues in China, however, no
studies to date examined the factors associated with the development of depression in patients with diabetes in
China. This study aimed to estimate the prevalence of co-morbid depression among adults with type 2 diabetes
mellitus (DM) and to examine the influence factors of co-morbid depression in a group of patients with type 2 DM.
Methods: The study was conducted from March l to May 31, 2012, in the Department of Endocrinology of the First
Affiliated Hospital of the General Hospital of the People’s Liberation Army (PLA). A systematic random sample of
412 type 2 DM patients aged over 18 years was selected. A structured questionnaire was used for collecting the
information about socio-demographic data, lifestyle factors and clinical characteristics. Depression and social
support was evaluated by using the Chinese version of Beck Depression Inventory (BDI) and Social Support Rate
Scale (SSRS), respectively. Weights and heights were measured. Hemoglobin A1c (HbA1c) was abstracted from each
patient directly after the interview.
Results: Of the total sample, 142 patients had depression according to the BDI scores (BDI scores ≥14), the
prevalence of co-morbid depression in this study population was 5.7 % (142/2500). Of which, 56 had major
depression (BDI ≥ 21), and 86 had moderate depression (BDI ≥ 14&BDI < 21). Logistic regression analysis indicated
that a high HbA1c level, a high BMI, low quality health insurance, and being single, were significantly associated
with the development of depression. However, a family history of diabetes and a high social support level are likely
protective factors.
Conclusions: The prevalence of co-morbid depression was 5.7 % among Chinese subjects with type 2 DM in this
study. High HbA1c level, high BMI score, being single, low social support level, and low quality health insurance
were associated with the presence of depression. These findings support a recommendation for routine screening
and management in China for depression in patients with diabetes, especially for those in primary care, to reduce
the number of the depressed or the misrecognized depressed diabetic patients.
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Diabetes was one of the most important public health
problems in China, and there were 113.9 million patients
with diabetes and 493.4 million patients with pre-
diabetes among Chinese adults in 2010 [1]. There was
also evidence that confirms the adverse economic im-
pacts of co-morbid diabetes and depression [2]. The
direct medical costs of type 2 DM and its complications
were projected to be 47.2 billion USD in 2030 [3]. Mean-
while, the total estimated cost of depression in China was
6264 million USD at 2002 prices [4]. Previous studies sug-
gested that the prevalence of depressive disorders and its’
risk factors may differ between countries and within coun-
tries, and across various ethnicities [5, 6]. It may be related
to the differences in either the presentation of symptoms
or a lack of cultural appropriateness of western methods
of identifying depression [7].
Evidence suggested that diabetes and depression could
mutually exacerbate, with each condition acting as a risk
factor in the development of the other [8–10]. Songar
et al. used a Beck’s Depression Inventory score of 14 as
cut-off and studied 60 diabetic patients and 30 healthy
controls, and found a prevalence of 43.3 % and 3.3 % re-
spectively [11]. In another study, conducted by Peyrot
and Rubin, a prevalence of 41.3 % was found among 634
diabetic patients, by using CES-D 16 as cut-off [12].
Pouwer et al. presented a prevalence of 32 % from a ran-
dom sample of 772 mixed cases of diabetes for study, by
using the composite international diagnostic interview
and CES-D (cut-off 16) [13]. Raval et al. reported a
prevalence of 41 % in North India by using the Patient
Health Questionnaire (PHQ)-9 scale [14], while Poongathai
et al. reported only 23.4 % from the South of India, by using
the PHQ-12 [15]. In 2014, Singh H et al. found a CES-D
defined depression prevalence of 42.2 % in diabetes patients
in india, which is 10 times higher than controls (4.39 %)
[16]. In a meta-analysis of 10 randomly controlled trials on
type 2 diabetes mellitus (DM) only, a significantly higher
prevalence of depression was found in people with diabetes
compared with those without (17.6 vs. 9.8 %, OR = 1.6,
95 % CI 1.2–2.0) [17]. A recent systematic review indi-
cated that individuals with previously diagnosed diabetes
have an increased risk of depression compared to those
with impaired glucose metabolism or undiagnosed dia-
betes (OR 1.69, 95 % CI 1.37–2.08) [18]. In addition, other
studies indicated that type 2 DM was a risk factor for de-
veloping depression [19, 20], the incidence of depression
was 1.8-times higher in the diabetic group than in nondia-
betic subjects over a median follow-up of 6.5 years [21].
Meanwhile, the prevalence of depression always varies
internationally among different populations [22]. The
higher depression prevalence was found in African
Americans with diabetes than in their counterparts of
white northern European ancestry [23, 24]. Even higherlevels of co-morbid diabetes and depression were also
shown in the US Latino population [25–28], Native
Americans [29], and Palestine [30]. Overall, it is now
generally agreed that the prevalence of depression in-
creased in people with diabetes, although the study, on
the Pima Indians in Arizona, found no significant differ-
ences in depressive symptoms between those with and
without diabetes [31]. Extensive researches had exam-
ined the risk factors of depression in patients with type
2 DM, the results varied widely across studies [22].
Depression risk factors that are specific to diabetes, in-
cluded co-morbidity of diabetes-related complications
[32], macro-vascular disease (stroke, peripheral artery
disease) [33], micro-vascular disease including retinop-
athy [34], neuropathy and nephropathy [35], longer dur-
ation of diabetes [36, 37], more demanding regimens
[38], negative life events [39], low levels of daily activities
[40, 41], physical activity [42], perceived burden of dia-
betes [43], diabetes diet, increased cholesterol and diffi-
culty in daily living [33], being a female, and being
widowed or divorced [44]. Besides, the depression symp-
toms was also significantly associated with poorer gly-
cemic control [45, 44, 46, 39], the level of HbA1c [45],
high fasting insulin values, 2-h glucose concentrations
and insulin resistance [47]. However, several studies
showed that the relationship between depression and
glycemic control/impaired fasting glucose was uncertain
[48] or insignificantly [49–51]. Another 5-year follow-up
study showed that previous depression history, baseline
diabetes symptoms, and having had cardiovascular pro-
cedures significantly predicted major depressive disorder
[34]. The course of depression in patients with diabetes
is chronic and severe [52], and has significant effects on
the outcome of their medical illness [53], including
lower quality of life [54], poorer diabetes self-care [55],
and an increased risk of developing diabetes-related
complications [32]. Just because of this, the International
Diabetes Federation (IDF) and National Institute for
Health and Clinical Excellence (NICE) recommended
that all patients with diabetes should undergo a regular
screening for depression [56, 57].
To date, no studies have examined the factors associ-
ated with depression in patients with diabetes in China.
This study aims to investigate the prevalence of depres-
sion and explore the influence factors associated with
depression in a group of patients with type 2 DM.
Methods
Participants
The study was conducted from March l to May 31,
2012, in the Department of Endocrinology of the First
Affiliated Hospital of the General Hospital of the
People’s Liberation Army (PLA), which is one of the best
medical centers in China. All of the patients above
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cording to the diagnostic criteria of the 10th revision of
the International Classification of Diseases (ICD-10)
[58], were selected from their medical records. The ex-
cluded patients were those having a history of psychi-
atric illness and those taking anti-depressant treatment
and/or using psychotropic drugs, considering that anti-
depressants or psychotropic drugs may influence the
outcome of BDI test. Eventually, there were 12 patients
excluded from this study, including 3 patients having a
history of psychiatric illness other than depression and 9
patients taking anti-depressant treatment, according to
the medical records. 450 subjects were recruited by cir-
cular systematic random sampling into this study from
2500 patients. Specifically, the number of 135 was
selected as the random starting point, and 6 was taken
as the sampling interval. All of the patients were
approached at the hospital by their attending diabetolog-
ist or diabetes nurse. Five diabetologists and 10 nurses
were in charge of completing a structured questionnaire,
including demographic information, BDI-21 test, and
Social Support Rate Scale (SSRS), measuring weight and
heights, and collecting the blood sample of subjects, in a
hospital waiting room. The whole process took about
20–30 min per subject. An instruction and scoring man-
ual was supplied to each diabetologist and specialized
diabetes nurse in this study. The study protocol was
approved by the School of Social Development and
Public Policy (SSDPP) ethics committee of Beijing Normal
University (BNU) and the research oversight committee of
the General Hospital of PLA. The patients were provided
written informed consents before the interview.
Measurements
Demographic information
The eligible subjects were interviewed using a structured
questionnaire. The demographic and socioeconomic
factors including age, gender, education level, marriage
status, and lifestyle factors (e.g., exercise times per week)
were collected.
Depression
The depressive symptoms were assessed with the
Chinese version of the self-administered 21-item Beck
Depression Inventory (BDI) [59], and a cut-off value ≥14
was used to define the cases with symptoms of depres-
sion in the Chinese population. Cronbach’s α of the BDI
in this study was 0.88.
Social support
Social support was evaluated by using the 14-item social
support rate scale (SSRS), which measures objective
support, subjective support, and useless support; it was
developed by Xiao Shuiyuan in 1986 and validated in aprevious study [60]. Cronbach’s alpha of the SSRS in this
sample was 0.74, the maximum scores were 50 and the
minimum scores were 20, respectively.
Clinical characteristics
Glycated Haemoglobin (HbA1c), which is used to
measure blood glucose control over several months and
provides an estimate of how well diabetes has been con-
trolled over the last 2 or 3 months, was abstracted from
each patient directly after the interview. HbA1c deter-
mination for all samples was done in the same labora-
tory by the same technician, who was blind to the
diagnosis results of the patients, and applying the same
technique. Weight and heights were also measured to
calculate the Body Mass Index (BMI). Other clinical
characteristics including disease duration, diabetes fam-
ily history, and diabetic complications (hypertension,
cardiac disease, diabetic nephropathy, diabetic retinop-
athy, and diabetic peripheral angiopathy) were obtained
from the standard medical records of the patients under
the permission of charge doctors.
Statistical analysis
The descriptive statistics were used in accordance with
the level of the variable measurements. The odds ratio
(OR) and its 95 % confidence intervals (CIs) were esti-
mated. The statistical significance of associations was
evaluated using the chi-square test, and the t test was
performed as appropriate. The level of statistical signifi-
cance was fixed at 0.05 for the bi-marginal null hypoth-
esis. Multivariate logistic regression analysis were
applied to explore the factors associated with depression
symptoms. The depression scores (≥14 versus <14) were
used as the dependent variable and the independent var-
iables including the demographic factors, clinical factors,
and behaviour factors were introduced into the multi-
variate logistic regression model, stepwise. All the data
were analysed by using SPSS 17.0 (SPSS Inc., Chicago,




412 patients participated in this study successfully, for a
response rate of 91.6 %. The other 38 patients, including
18 males, explicitly declined participation in the screen-
ing when they were approached by a nurse in the wait-
ing room. These 38 patients did not differ in the
demographic variables and the part clinical variables
compared with the respondents (Additional file 1). The
average age of the sample was 59.77 years (SD 12.48),
with a range of 25 to 89 years; 53.6 % of the sample were
over 60, and females comprised 49.8 % of the sample.
For all the respondents, 70.1 % were married or living
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ried, divorced and widowed). Of the total sample, 13.3 %
had a primary education (≤6 years), 39.5 % had com-
pleted junior middle school/high school (6–12 years),
and 47.1 % had a junior college or more advanced
education. Regarding employment, a high percentage of
the subjects was retired (62.1 %), followed by being
employed (33.5 %) and being unemployed (4.4 %)
(Table 1).
Clinical characteristics and frequency of depression
Of the total sample, the average duration of diabetes was
8.93 years (SD 6.51), ranging from 1–36 years. Specific-
ally, the average duration of diabetes for the patients
with depression symptoms was longer than that without
depression symptoms (10.32 ± 7.52 vs 8.20 ± 5.79, t = −3.17;
P = 0.002). In addition, 83.3 % of the sample had diabetes
complications, and the most frequently diagnosed compli-
cations were hypertension (88.9 %), abnormal blood lipids
(70.3 %), cardiovascular disease (28.6 %), and diabetic per-
ipheral neuropathy (25.4 %). The other complications
rates included the following: diabetic retinopathy (20.7 %),
cerebrovascular disease (19.0 %), lower limb angiopathy
(14.6 %), renal diseases (11.4 %), and other complications
(8.2 %).
One hundred and forty two patients (34.5 %) experi-
enced symptoms of depression (BDI ≥ 14), and the
prevalence of co-morbid depression was 5.7 % in this
study population; 56 patients had major depression
(BDI ≥ 21), and 86 patients had moderate depression
(BDI ≥ 14&BDI < 21). The patients with symptoms of
depression had lower levels of social support (t = 12.60;
P < 0.001), and presented poorer glycemic control (χ2 =
9.72; P = 0.002), a longer duration of diabetes (t = −3.17;
P = 0.002), and greater number of complications (t = −4.98;
P = 0.00) as well as had fewer hours of sleep per day
(t = 4.38; P < 0.001) and fewer exercise sessions per
week (t = 3.35; P < 0.001), compared with the patients
without depression (Table 1). The patients with a
family history of diabetes presented a lower prevalence of
depression symptoms (24.2 % vs 43.2 %, χ2 = 16.42; P <
0.001), compared to the patients without a family history
of diabetes in this sample (Table 1).
Risk and protective factors associated with depression
In this study, no significant differences were observed
among the patients in different age group diabetes
(Table 2). Regarding marital status, being single was a
significant risk factor (OR 2.51; 95 % CI: 1.29–4.90; P =
0.007) compared with being married. The patients cov-
ered by Urban Employees Basic Medical Insurance
(UEMI) were more likely to suffer from depression
symptoms (OR 2.38; 95 % CI: 1.12–5.04; P = 0.024) com-
pared with the patients covered by the GovernmentEmployee Insurance Scheme (GIS). Consistent with previ-
ous findings, social support was also identified as a pro-
tective factor (OR 0.76; 95 % CI: 0.69–0.83; P < 0.0001)
(Table 2).
With regard to the clinical characteristics, two risk fac-
tors for depression symptoms were identified, including a
higher glycated hemoglobin level (HbA1c ≥7.00 %, OR
1.89; 95 % CI: 1.10–3.53; P = 0.045), and a higher body-
mass index (BMI ≥ 25 kg/m2; OR 1.12; 95 % CI: 1.02–1.24;
P = 0.024). A family history of diabetes was also identified
as a protective factor (OR 0.49; 95 % CI: 0.26–0.90; P =
0.022) in this study.
Discussion
Depressive symptoms impede diabetes care tasks and
negatively influence health status [61, 62]; furthermore,
these depression symptoms not only can’t be identified
by the patients, but also can’t be recognized by care pro-
viders [61], hence, leading to under-treatment [63]. In
this study, we documented that 5.7 % of a study popula-
tion of type 2 DM patients had symptoms of depression.
The prevalence was lower than that reported in India
(23.4 % and above) [11, 14–16] and in Baltimore of USA
(41.3 %) [12]. Increased risk of depression in patients
with diabetes may be attributed to lifestyle and health
behaviors, the previous studies suggested the following
important factors are related to depression in patients
with diabetes: the occurrence of chronic or acute com-
plications, persistent poor glycemic control and the need
for insulin therapy [46, 64, 48]. In this study, we found
that a higher HbA1c level was a risk factor for the pres-
ence of depression symptoms, rather than the number of
diabetes complications. Another two studies have also
suggested that depression was strongly associated with
poor glycemic control and the number of co-morbid
conditions [46, 64]. There was a different result from an-
other study conducted by Pouwer F et al [65], which
showed that the prevalence of depression increased in
patients with type 2 DM and co-morbid chronic dis-
eases, but not in patients with type 2 DM only. In
addition, functional limitations that often accompany
co-morbid chronic disease could play an essential role in
the development of depression in type 2 diabetes [65].
Similarly, a recent study suggested that micro- and
macro-vascular diabetic complications were associated
with depression [66]. Some researchers noted that this
may be resulted from the differences in either the pres-
entation of symptoms or a lack of cultural appropriate-
ness of western methods of identifying depression [22,
17]. Lloyd CE etal found that the variation in symptoms
and ways to describe depressive symptomatology can be
seen as culturally influenced [7]. However, the mechan-
ism for these differences still remains unclear, and
should be further examined in the future. For example,
Table 1 Co-morbid depression (BDI score ≥ 14) and demographic, clinical, and behavior characteristics by depression groups
Variables Total sample (n) No depression n(%) Depression n(%) Significance
n(%) 412 270(65.53) 142(34.47)
Demographic factors
Men 207(50.24) 134(49.63) 73(51.41) (χ2 = 0.12;P = 0.73)
Female 205 (49.76) 136(66.3) 69(33.7)
Age (years)
<40 26(6.31) 9(3.33) 17(11.97) (χ2 = 21.51; P = 0.00)
40–59 165(40.05) 126(46.67) 39(27.46)
≥60 221(53.64) 135(50.00) 86(60.56)
High school or less 218(52.91) 133(49.26) 85(59.86) (χ2 = 4.20; P = 0.04)
Being ingle 123(29.85) 48(17.78) 75(52.82) (χ2 = 54.55; P = 0.00)
Employment status
Employed 138(33.50) 94(34.81) 44(30.99) (χ2 = 6.09; P = 0.048)
Unemployed 18(4.37) 7(2.59) 11(7.75)
Retired 256(62.14) 169(62.59) 87(61.27)
Insurance
GIS 130(31.55) 99(36.67) 31(21.83) (χ2 = 22.88; P = 0.00)
UEMI 112(27.18) 68(25.19) 44(30.99)
URMI 102(24.76) 60(22.22) 42(29.58)
NCMS 17(4.13) 16(5.93) 1(0.70)
Other insurance 19(4.61) 7(2.59) 12(8.45)
None insurance 32(7.77) 20(7.41) 12(8.45)
Social support 31.35 ± 5.50 33.45 ± 4.53 27.35 ± 4.94 (t = 12.60; P = 0.00)
Clinical factors
HbA1c level
<7.00 % 209(50.73) 152(56.30) 57(40.14) (χ2 = 9.72; P = 0.002)
≥7.00 % 203(49.27) 118(43.70) 85(59.86)
BMI(kg/m2)
<25 215(52.18) 142(52.59) 73(51.41) (χ2 = 0.05; P = 0.0819)
≥25 197(47.82) 128(47.41) 69(48.59)
History of diabetes 190(46.12) 144(53.33) 46(32.39) (χ2 = 16.42; P = 0.00)
Duration of diabetes in years 8.93 ± 6.51 8.20 ± 5.79 10.32 ± 7.52 (t = −3.17; P = 0.002)
Diabetes complications 2.39 ± 1.90 2.06 ± 1.58 3.01 ± 2.28 (t = −4.98; P = 0.00)
Oral agents 227(55.10) 148(55.64) 79(54.11) (χ2 = 0.137; P = 0.76)
Insulin 185(44.90) 118(44.36) 67(45.89)
Behavior factors
Smoking currently 112(27.18) 80(29.63) 32(22.54) (χ2 = 2.37; P = 0.12)
Drinking currently 198(48.06) 143(52.96) 55(38.73) (χ2 = 7.55; P = 0.006)
Excise times per week 1.67 ± 2.78 2.00 ± 2.79 1.04 ± 2.67 (t = 3.35; P = 0.00)
Sleeping hours per day 5.95 ± 2.82 6.38 ± 1.22 5.13 ± 4.39 (t = 4.38; P = 0.00)
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culturally distinctive understandings of the causes of de-
pression, the effects of particular health problems, and
help-seeking in the community if identification andtreatment of co-morbid diabetes and depression is to be
improved [22].
In addition, a higher BMI (≥25 kg/m2) was also identi-
fied as a risk factor for depression symptoms in this
Table 2 Multivariate logistic regression model predicting
co-morbid depression (BDI score ≥ 14) by demographic, clinical,
and behavior factors (n = 412)




40–59 years vs. <40 years 0.29(0.09,0.97)
≥60 years vs. <40 years 0.58(0.15,2.27)
High school or less 0.94(0.45,1.80)
Being single 2.51(1.29,4.90)
Employment status
Unemployed vs. employed 4.39(0.89,21.77)
Retired vs. employed 0.74(0.31,1.76)
Insurance
UEMI vs. GIS 2.38(1.12,5.04)
URMI vs. GIS 0.95(0.40,2.27)
NCMS vs. GIS 0.18(0.19,1.82)
Other insurance vs. GIS 1.64(0.38,7.06)
None insurance vs. GIS 0.77(0.22,2.65)
Social support 0.76(0.69,0.83)
Clinical factors
HbA1c ≥7.00 % 1.89(1.10,3.53)
BMI ≥25 kg/m2 1.12(1.02,1.24)
History of diabtes 0.49(0.26,0.90)







Excise times per week 0.92(0.46,1.86)
Sleeping hours per day 0.82(0.67,1.00)
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indicated that the BMI contributed to depression indir-
ectly via diabetes-related medical symptoms. Previous
study showed that insulin therapy has a significant asso-
ciation with depression among adult patients with dia-
betes [68], however, insulin therapy wasn’t associated
with the depression symptoms in this study, this may be
related to the characteristics and the size of this sample.
It’s interesting that a family history of diabetes was
identified as a protective factor against symptoms of de-
pression in patients with diabetes in this study. A previ-
ous study suggested that an increase in knowledge
concerning diabetes care could relieve symptoms ofanxiety and depression [69]. A positive family setting
provides an opportunity for a patient to obtain personal
experience in chronic disease management and conse-
quently manage his/her own disease more effectively
[70]. Another protective factor against the presence of
depression symptoms was the high social support level
in this study. Previous study also confirmed this result,
which suggested that if social support level can be
strengthened in patients with type 2 DM, psychological
factors can be improved [71]. A mediation analysis indi-
cated that the effect of social support on diabetes-related
medical symptoms was fully accounted for by social sup-
port’s adverse effect on depression [72]. A community-
based study on the patients with type 2 DM, in China,
showed that high salary and more subjective social sup-
port could improve the quality of life in diabetic patients
with depressive symptoms [73].
Being single, including being unmarried, widowed, and
divorced, was also identified as a risk factor for symp-
toms of depression, which coincides with the results as
reported by José Francisco [46] and M. M. Collins [48].
Being different from the previous studies, which showed
that women with or without diabetes experience a
higher prevalence of depression than men [62, 64, 48,
74], no significant difference was observed between
males and females in this study. The reasons for these
differences are unclear and should be further examined
in the future, which is most likely connected with the vari-
ance of research methods and population characteristics.
In addition, we found that the patients covered by
UEMI were more likely to suffer from symptoms of
depression compared with the patients covered by GIS.
In China, the patients covered by GIS have the highest
reimbursement rates, so they had a lighter burden of
medical care and less disease-related mental stress than
the patients, covered by UEMI, who personally incur
high medical expenses.
Type 2 DM is a crucial public health issue in China, with
massive medical, social, and economic effects; few studies
focus on depression in patients with diabetes. The results
of this study should be further confirmed in the future, and
should be investigated in different populations, to present
a more comprehensive representation of the magnitude of
this problem. The incidence of depression in patients with
type 2 DM mellitus should be paid more attention.
Limitations
Our study may be the first to be conducted in China to
investigate the prevalence and influencing factors of un-
diagnosed depression depression in patients with type 2
diabetes mellitus. Systematic random sampling technique,
Beck Depression Inventory (BDI), and Social Support Rate
Scale (SSRS) were also used in our study. However, our
study has a few limitations. First, the samples were
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all of the patients in China. Second, the excluding cases of
diagnosed depression in this study also had influence on
the prevalence of depression symptoms among the pa-
tients with type 2 DM. Third, this study is cross-sectional
where causal relationship between diabetes and depression
cannot be established. Variables identified as significantly
associated with depression may precede depression, but in
some cases, these variables could also occur as a result of
depression; thus, high BDI scores among patients with
diabetes must be interpreted with caution. Longitudinal
prospective studies are needed to shed more light on the
potential relationship between depression and diabetes
mellitus in the future.
Conclusions
The prevalence of co-morbid depression was 5.7 %
among Chinese subjects with type 2 DM in this study.
High HbA1c level, high BMI score, being single, and low
quality health insurance were associated with the pres-
ence of depression. These findings support a recommen-
dation for routine screening in China for depression in
patients with diabetes, especially for those in primary
care, to reduce the number of the depressed or the mis-
recognized depressed diabetic patients and consequently
offer them a better quality of life.
Additional file
Additional file 1: The characteristic of non-responders in this study.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
DT, ZQ and SY gave us the idea of this study. WZ, HX and SZ participated in
the design and conducted the research as well as drafted the manuscript.
XW and JG helped revise the manuscript. SY gave us a lot of help during the
process of this study, SZ, HZ, FW, LG, HY, and LZ provided the data analysis
help. All the authors read and approved the final manuscript.
Acknowledgments
We thank Beijing Normal University for giving financial support. We also
thank the hospital officials and the data collectors for providing the support
for this study, and all the respondents for participating our study.
Funding sources
This study was supported by the Fundamental Research Funds for the
Central Universities (No: SKZZX2013053 in Beijing Normal University).
Author details
1School of Social Development and Public Policy, China Institute of Health,
Beijing Normal University, 19, Xinjiekou Wai Street, Beijing 100875, China.
2Department of Public Health Sciences, University of Rochester School of
Medicine & Dentistry, Rochester, NY 14642, USA. 3School of Public
Administration, Yunnan University of Finance and Economics, Kunming 650221,
China. 4Department of Endocrinology, First Affiliated Hospital of the General
Hospital of the People’s Liberation Army (PLA), Beijing 100853, China.
5Department of Sociology, Huazhong University of Science and Technology,
1037 Luoyu Road, Wuhan 430074, China. 6School of Government, Beijing
Normal University, 19, Xinjiekou Wai Street, Beijing 100875, China.Received: 16 March 2015 Accepted: 17 June 2015References
1. Xu Y, Wang L, He J, Bi Y, Li M, Wang T, et al. Prevalence and control of
diabetes in Chinese adults. JAMA. 2013;310(9):948–59. doi:10.1001/
jama.2013.168118.
2. Molosankwe I, Patel A, José Gagliardino J, Knapp M, McDaid D. Economic
aspects of the association between diabetes and depression: A systematic
review. J Affect Disord. 2012;142(Supplement(0)):S42–55. http://dx.doi.org/
10.1016/S0165-0327(12)70008-3.
3. Wang W, McGreevey WP, Fu C, Zhan S, Luan R, Chen W, et al. Type 2
diabetes mellitus in China: a preventable economic burden. Am J Manag
Care. 2009;15(9):593–601.
4. Hu TW, He Y, Zhang M, Chen N. Economic costs of depression in China. Soc
Psychiatry Psychiatr Epidemiol. 2007;42(2):110–6. doi:10.1007/s00127-006-0151-2.
5. Chaudhry I, Neelam K, Duddu V, Husain N. Ethnicity and
psychopharmacology. J Psychopharmacol. 2008;22(6):673–80. doi:10.1177/
0269881107082105.
6. Bhugra D, Bhui K. Ethnic and cultural factors in psychopharmacology. Adv
Psychiatr Treat. 1999;5:89–95.
7. Lloyd CE, Roy T, Begum S, Mughal S, Barnett AH. Measuring psychological
well-being in South Asians with diabetes; a qualitative investigation of the
PHQ-9 and the WHO-5 as potential screening tools for measuring symptoms of
depression. Diabet Med. 2012;29(1):140–7. doi:10.1111/j.1464-5491.2011.03481.x.
8. Nouwen A, Winkley K, Twisk J, Lloyd CE, Peyrot M, Ismail K, et al. Type 2
diabetes mellitus as a risk factor for the onset of depression: a systematic
review and meta-analysis. Diabetologia. 2010;53(12):2480–6. doi:10.1007/
s00125-010-1874-x.
9. El-Hechmi S, Zgueb Y, Jomli R, Ouanes S, Nacef F, Turki Z. 2859 –
Depression and diabetes comorbidity: prevalence and clinical features. Eur
Psychiatry. 2013;28(Supplement 1(0)):1. http://dx.doi.org/10.1016/S0924-
9338(13)77440-6.
10. Kokoszka A, Pouwer F, Jodko A, Radzio R, Mućko P, Bieńkowska J, et al.
Serious diabetes-specific emotional problems in patients with type 2 dia-
betes who have different levels of comorbid depression: A Polish study
from the European Depression in Diabetes (EDID) Research Consortium. Eur
Psychiatry. 2009;24(7):425–30. http://dx.doi.org/10.1016/j.eurpsy.2009.04.002.
11. Songar A, Kocabaşoğlu N, Balcioğlu İ, Karaca E, Kocabaşoğlu C, Hacıosman
M, et al. The relationship between diabetics’ metabolic control levels and
psychiatric symptomatology. Integr Psychiatry. 1993;9(1):34–40.
12. Peyrot M, Rubin RR. Levels and risks of depression and anxiety
symptomatology among diabetic adults. Diabetes Care. 1997;20(4):585–90.
13. Pouwer F, Kupper N, Adriaanse MC. Does emotional stress cause type 2
diabetes mellitus? A review from the European Depression in Diabetes
(EDID) Research Consortium. Discov Med. 2010;9(45):112–8.
14. Raval A, Dhanaraj E, Bhansali A, Grover S, Tiwari P. Prevalence &
determinants of depression in type 2 diabetes patients in a tertiary care
centre. Indian J Med Res. 2010;132:195–200.
15. Poongothai S, Anjana RM, Pradeepa R, Ganesan A, Unnikrishnan R, Rema M,
et al. Association of depression with complications of type 2 diabetes–the
Chennai Urban Rural Epidemiology Study (CURES- 102). J Assoc Physicians
India. 2011;59:644–8.
16. Singh H, Raju MSVK, Dubey V, Kurrey R, Bansal S, Malik M. A study of
sociodemographic clinical and glycemic control factors associated with
co-morbid depression in type 2 diabetes mellitus. Ind Psychiatry J.
2014;23(2):134–42.
17. Ali S, Stone MA, Peters JL, Davies MJ, Khunti K. The prevalence of co-morbid
depression in adults with Type 2 diabetes: a systematic review and
meta-analysis. Diabet Med. 2006;23(11):1165–73. doi:10.1111/j.1464-
5491.2006.01943.x.
18. Nouwen A, Nefs G, Caramlau I, Connock M, Winkley K, Lloyd CE, et al.
Prevalence of depression in individuals with impaired glucose metabolism
or undiagnosed diabetes: a systematic review and meta-analysis of the
European Depression in Diabetes (EDID) Research Consortium. Diabetes
Care. 2011;34(3):752–62. doi:10.2337/dc10-1414.
19. Hasan SS, Mamun AA, Clavarino AM, Kairuz T. Incidence and risk of
depression associated with diabetes in adults: evidence from longitudinal
studies. Community Ment Health J. 2015;51(2):204–10. doi:10.1007/s10597-
014-9744-5.
Zhang et al. Diabetology & Metabolic Syndrome  (2015) 7:60 Page 8 of 920. Rotella F, Mannucci E. Diabetes mellitus as a risk factor for depression. A
meta-analysis of longitudinal studies. Diabetes Res Clin Pract. 2013;99(2):98–104.
doi:10.1016/j.diabres.2012.11.022.
21. Hsu YM, Su LT, Chang HM, Sung FC, Lyu SY, Chen PC. Diabetes mellitus and
risk of subsequent depression: a longitudinal study. Int J Nurs Stud.
2012;49(4):437–44. doi:10.1016/j.ijnurstu.2011.09.019.
22. Lloyd CE, Roy T, Nouwen A, Chauhan AM. Epidemiology of depression in
diabetes: international and cross-cultural issues. J Affect Disord.
2012;142(Suppl):S22–9. doi:10.1016/S0165-0327(12)70005-8.
23. Gary TL, Crum RM, Cooper-Patrick L, Ford D, Brancati FL. Depressive
symptoms and metabolic control in African-Americans with type 2 diabetes.
Diabetes Care. 2000;23(1):23–9.
24. Thomas J, Jones G, Scarinci I, Brantley P. A descriptive and comparative
study of the prevalence of depressive and anxiety disorders in low-income
adults with type 2 diabetes and other chronic illnesses. Diabetes Care.
2003;26(8):2311–7.
25. Trief PM, Morin PC, Izquierdo R, Teresi J, Eimicke JP, Goland R, et al.
Depression and glycemic control in elderly ethnically diverse patients with
diabetes: the IDEATel project. Diabetes Care. 2006;29(4):830–5.
26. Egede LE, Zheng D. Independent factors associated with major depressive
disorder in a national sample of individuals with diabetes. Diabetes Care.
2003;26(1):104–11.
27. Bell RA, Smith SL, Arcury TA, Snively BM, Stafford JM, Quandt SA. Prevalence
and correlates of depressive symptoms among rural older African
Americans, Native Americans, and whites with diabetes. Diabetes Care.
2005;28(4):823–9.
28. Fisher L, Chesla CA, Mullan JT, Skaff MM, Kanter RA. Contributors to
depression in Latino and European-American patients with type 2 diabetes.
Diabetes Care. 2001;24(10):1751–7.
29. Singh PK, Looker HC, Hanson RL, Krakoff J, Bennett PH, Knowler WC.
Depression, diabetes, and glycemic control in Pima Indians. Diabetes Care.
2004;27(2):618–9.
30. Sweileh WM, Abu-Hadeed HM, Al-Jabi SW, Zyoud SH. Prevalence of depression
among people with type 2 diabetes mellitus: a cross sectional study in
Palestine. BMC Public Health. 2014;14:163. doi:10.1186/1471-2458-14-163.
31. Sahota PK, Knowler WC, Looker HC. Depression, diabetes, and glycemic
control in an American Indian community. J Clin Psychiatry.
2008;69(5):800–9.
32. de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association
of depression and diabetes complications: a meta-analysis. Psychosom Med.
2001;63(4):619–30.
33. Bruce DG, Casey G, Davis WA, Starkstein SE, Clarnette RC, Foster JK, et al.
Vascular depression in older people with diabetes. Diabetologia.
2006;49(12):2828–36. doi:10.1007/s00125-006-0478-y.
34. Katon W, Russo J, Lin EH, Heckbert SR, Ciechanowski P, Ludman EJ, et al.
Depression and diabetes: factors associated with major depression at
five-year follow-up. Psychosomatics. 2009;50(6):570–9. doi:10.1176/
appi.psy.50.6.570.
35. van Steenbergen-Weijenburg KM, van Puffelen AL, Horn EK, Nuyen J, van
Dam PS, van Benthem TB, et al. More co-morbid depression in patients with
Type 2 diabetes with multiple complications. An observational study at a
specialized outpatient clinic. Diabet Med. 2011;28(1):86–9.
36. Padgett DK. Sociodemographic and disease-related correlates of depressive
morbidity among diabetic patients in Zagreb, Croatia. J Nerv Ment Dis.
1993;181(2):123–9.
37. Bruce DG, Davis WA, Davis TM. Longitudinal predictors of reduced mobility
and physical disability in patients with type 2 diabetes: the Fremantle
Diabetes Study. Diabetes Care. 2005;28(10):2441–7.
38. Surwit RS, van Tilburg MA, Parekh PI, Lane JD, Feinglos MN. Treatment
regimen determines the relationship between depression and glycemic
control. Diabetes Res Clin Pract. 2005;69(1):78–80. doi:10.1016/
j.diabres.2004.11.002.
39. Naranjo DM, Fisher L, Arean PA, Hessler D, Mullan J. Patients with type 2
diabetes at risk for major depressive disorder over time. Ann Fam Med.
2011;9(2):115–20. doi:10.1370/afm.1212.
40. Wikblad KF, Wibell LB, Montin KR. Health and unhealth in chronic disease.
Scand J Caring Sci. 1991;5(2):71–7.
41. Pawaskar MD, Anderson RT, Balkrishnan R. Self-reported predictors of
depressive symptomatology in an elderly population with type 2 diabetes
mellitus: a prospective cohort study. Health Qual Life Outcomes. 2007;5:50.
doi:10.1186/1477-7525-5-50.42. Lysy Z, Da Costa D, Dasgupta K. The association of physical activity and
depression in Type 2 diabetes. Diabet Med. 2008;25(10):1133–41.
doi:10.1111/j.1464-5491.2008.02545.x.
43. Polonsky WH, Anderson BJ, Lohrer PA, Welch G, Jacobson AM, Aponte JE,
et al. Assessment of diabetes-related distress. Diabetes Care.
1995;18(6):754–60.
44. Golden SH, Lazo M, Carnethon M, Bertoni AG, Schreiner PJ, Diez Roux AV,
et al. Examining a bidirectional association between depressive symptoms
and diabetes. JAMA. 2008;299(23):2751–9. doi:10.1001/jama.299.23.2751.
45. Fisher L, Skaff MM, Mullan JT, Arean P, Glasgow R, Masharani U. A
longitudinal study of affective and anxiety disorders, depressive affect and
diabetes distress in adults with Type 2 diabetes. Diabet Med.
2008;25(9):1096–101. doi:10.1111/j.1464-5491.2008.02533.x.
46. Tellez-Zenteno JF, Cardiel MH. Risk factors associated with depression in
patients with type 2 diabetes mellitus. Arch Med Res. 2002;33(1):53–60.
47. Holt RI, Phillips DI, Jameson KA, Cooper C, Dennison EM, Peveler RC. The
relationship between depression and diabetes mellitus: findings from the
Hertfordshire Cohort Study. Diabet Med. 2009;26(6):641–8. doi:10.1111/
j.1464-5491.2009.02742.x.
48. Collins MM, Corcoran P, Perry IJ. Anxiety and depression symptoms in
patients with diabetes. Diabet Med. 2009;26(2):153–61. doi:10.1111/j.1464-
5491.2008.02648.x.
49. Engum A. The role of depression and anxiety in onset of diabetes in a large
population-based study. J Psychosom Res. 2007;62(1):31–8. doi:10.1016/
j.jpsychores.2006.07.009.
50. Lin EH, Heckbert SR, Rutter CM, Katon WJ, Ciechanowski P, Ludman EJ, et al.
Depression and increased mortality in diabetes: unexpected causes of
death. Ann Fam Med. 2009;7(5):414–21. doi:10.1370/afm.998.
51. Knol MJ, Heerdink ER, Egberts AC, Geerlings MI, Gorter KJ, Numans ME, et al.
Depressive symptoms in subjects with diagnosed and undiagnosed type 2
diabetes. Psychosom Med. 2007;69(4):300–5. doi:10.1097/
PSY.0b013e31805f48b9.
52. Katon WJ. The comorbidity of diabetes mellitus and depression. Am J Med.
2008;121(11 Suppl 2):S8–S15. doi:10.1016/j.amjmed.2008.09.008.
53. Wu SF, Huang YC, Liang SY, Wang TJ, Lee MC, Tung HH. Relationships among
depression, anxiety, self-care behaviour and diabetes education difficulties in
patients with type-2 diabetes: a cross-sectional questionnaire survey. Int J Nurs
Stud. 2011;48(11):1376–83. doi:10.1016/j.ijnurstu.2011.04.008.
54. Schram MT, Baan CA, Pouwer F. Depression and quality of life in patients
with diabetes: a systematic review from the European depression in
diabetes (EDID) research consortium. Curr Diabetes Rev. 2009;5(2):112–9.
55. Gonzalez JS, Peyrot M, McCarl LA, Collins EM, Serpa L, Mimiaga MJ, et al.
Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes
Care. 2008;31(12):2398–403. doi:10.2337/dc08-1341.
56. International Diabetes Federation. Global guideline for type 2 diabetes.
Available from http://www.idf.org/global-guideline-type-2-diabetes-2012,
accessed 28 September 20132012.
57. Jones AG, Knight BA, Baker GC, Hattersley AT. Practical implications of
choice of test in National Institute for Health and Clinical Excellence (NICE)
guidance for the prevention of Type 2 diabetes. Diabet Med.
2013;30(1):126–7. doi:10.1111/dme.12025.
58. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes
mellitus and its complications. Part 1: diagnosis and classification of
diabetes mellitus provisional report of a WHO consultation. Diabet Med.
1998;15(7):539–53. doi:10.1002/(SICI)1096-9136(199807)15:7<539::AID-
DIA668>3.0.CO;2-S.
59. Zheng YP, Wei LA, Goa LG, Zhang GC, Wong CG. Applicability of
the Chinese Beck Depression Inventory. Compr Psychiatry.
1988;29(5):484–9.
60. Shuiyuan X. Theoretical Background Study and Application of Social
Support Rate Scale (in Chinese). J Clin Psychiatry. 1994;02:98–100.
61. Fleer J, Tovote KA, Keers JC, Links TP, Sanderman R, Coyne JC, et al.
Screening for depression and diabetes-related distress in a diabetes out-
patient clinic. Diabet Med. 2013;30(1):88–94. doi:10.1111/dme.12001.
62. Roy T, Lloyd CE. Epidemiology of depression and diabetes: a systematic
review. J Affect Disord. 2012;142(Suppl):S8–S21. doi:10.1016/S0165-
0327(12)70004-6.
63. Li C, Ford ES, Zhao G, Balluz LS, Berry JT, Mokdad AH. Undertreatment of
mental health problems in adults with diagnosed diabetes and serious
psychological distress: the behavioral risk factor surveillance system, 2007.
Diabetes Care. 2010;33(5):1061–4. doi:10.2337/dc09-1515.
Zhang et al. Diabetology & Metabolic Syndrome  (2015) 7:60 Page 9 of 964. Icks A, Kruse J, Dragano N, Broecker-Preuss M, Slomiany U, Mann K, et al.
Are symptoms of depression more common in diabetes? Results from the
Heinz Nixdorf Recall study. Diabet Med. 2008;25(11):1330–6. doi:10.1111/
j.1464-5491.2008.02585.x.
65. Pouwer F, Beekman AT, Nijpels G, Dekker JM, Snoek FJ, Kostense PJ, et al.
Rates and risks for co-morbid depression in patients with Type 2 diabetes
mellitus: results from a community-based study. Diabetologia.
2003;46(7):892–8. doi:10.1007/s00125-003-1124-6.
66. Siddiqui S. Depression in type 2 diabetes mellitus—A brief review. Diabetes
& Metabolic Syndrome: Clinical Research & Reviews. 2013. http://dx.doi.org/
10.1016/j.dsx.2013.06.010.
67. Sacco WP, Wells KJ, Friedman A, Matthew R, Perez S, Vaughan CA.
Adherence, body mass index, and depression in adults with type 2 diabetes:
the mediational role of diabetes symptoms and self-efficacy. Health Psychol.
2007;26(6):693–700. doi:10.1037/0278-6133.26.6.693.
68. Al-Amer RM, Sobeh MM, Zayed AA, Al-Domi HA. Depression among adults
with diabetes in Jordan: risk factors and relationship to blood sugar control.
J Diabetes Complicat. 2011;25(4):247–52. doi:10.1016/j.jdiacomp.2011.03.001.
69. Rubin RR, Peyrot M, Saudek CD. Effect of diabetes education on self-care,
metabolic control, and emotional well-being. Diabetes Care.
1989;12(10):673–9.
70. Fan CA, Sattler L, Parkinson C, Thekadeth BG, Singh SP, Perlmuter LC. The
effect of family history of diabetes on sleep quality, depression, and anxiety
in adult males with diabetes. J Diabetes Mellitus. 2013;3(01):11–4.
71. Wu SF, Young LS, Yeh FC, Jian YM, Cheng KC, Lee MC. Correlations among
social support, depression, and anxiety in patients with type-2 diabetes. J
Nurs Res. 2013;21(2):129–38. doi:10.1097/jnr.0b013e3182921fe1.
72. Sacco WP, Yanover T. Diabetes and depression: the role of social support
and medical symptoms. J Behav Med. 2006;29(6):523–31. doi:10.1007/
s10865-006-9072-5.
73. Liu Y, Maier M, Hao Y, Chen Y, Qin Y, Huo R. Factors related to quality of life
for patients with type 2 diabetes with or without depressive symptoms - results
from a community-based study in China. J Clin Nurs. 2013;22(1–2):80–8.
doi:10.1111/jocn.12010.
74. Lyrakos GN, Papazafiropoulou AK, Batistaki C, Xatziagelaki E, Damigos D, Tinas
C, et al. 1412 – Differences in depression anxiety and stress among men and
women with diabetes mellitus. Eur Psychiatry. 2013;28(Supplement 1(0)):1.
http://dx.doi.org/10.1016/S0924-9338(13)76450-2.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
